NCT06097728 2026-03-04
eVOLVE-Meso
AstraZeneca
Phase 3 Recruiting
Clinical Trials
13 trialsNCT07412613 2026-02-27
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
Akeso
Phase 3 Not yet recruiting
NCT06513962 2026-02-24
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Children's Oncology Group
Phase 3 Recruiting
NCT02320435 2026-02-12
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT04334759 2026-01-22
DREAM3R
PrECOG, LLC.
Phase 3 Completed
NCT03996265 2026-01-15
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
University of Rochester
Phase 3 Active not recruiting
NCT06395441 2025-12-26
Wisconsin Ginseng for Decreasing Cancer Related Fatigue
Mayo Clinic
Phase 3 Recruiting
NCT07174453 2025-12-08
Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies
University of Kansas Medical Center
Phase 3 Recruiting
NCT06587490 2025-10-14
TRITONS
University of California, San Diego
Phase 3 Recruiting
NCT04409236 2025-09-17
Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
Fred Hutchinson Cancer Center
Phase 3 Active not recruiting
NCT00186888 2025-09-04
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
St. Jude Children's Research Hospital
Phase 3 Completed
NCT03710876 2025-05-20
INFINITE
Ferring Ventures Limited
Phase 3 Active not recruiting
NCT03063450 2025-04-10
CONFIRM
University of Southampton
Phase 3 Completed